In 2025, tobacco excise in Australia is creating a structural divide across ASX exposures: convenience-store and petrol-station operators face falling legal tobacco volumes, reduced foot traffic and illicit-market risks, while ASX-listed pharmacy operators may benefit from cessation demand and pharmacy-based vaping. Consumer discretionary spending and tobacco-exposed ETFs also warrant scrutiny as portfolios adjust.
Most commentary on tobacco excise focuses on health outcomes. This article maps those forces to specific ASX sector exposures and helps you identify where the genuine portfolio risk and opportunity lies heading into the second half of 2025.
How does tobacco excise affect ASX stocks?
The ATO Mechanism Behind the Price Rises
Australia’s tobacco excise is adjusted twice yearly — in March and September — in line with Average Weekly Ordinary Time Earnings (AWOTE), a wage growth measure published by the ABS. From 1 September 2023, an additional 5% annual increase was layered on top of this indexation for three consecutive years.
This compounds significantly. Retail cigarette prices reflect both AWOTE indexation and the stacked 5% annual increases. Because the ATO administers these rates under a legislated schedule, ongoing price rises are a policy certainty, not a speculative budget risk.
Three Decades of Declining Smoking Rates: The Structural Backdrop
Daily smoking among Australians aged 14 and over fell from 24% in 1991 to 5.6% in 2025 (AIHW National Drug Strategy Household Survey, 2025). Policy levers have included plain packaging introduced in 2012, graphic health warnings, and escalating excise — a classic Pigouvian tax design that prices negative externalities into consumer behaviour.
This is a generational shift, not a cyclical dip. The addressable market for tobacco-linked retail revenue is permanently contracting.
Which ASX companies benefit from tobacco excise?
Convenience Store and Petrol Station Revenue Exposure
Tobacco products represent a substantial share of total revenue at Australian convenience store and petrol station formats. As per-unit prices rise, legal volumes are falling — creating a volume-versus-price squeeze that operators cannot fully offset through price alone.
Tobacco purchases also anchor basket spend. Customers buying cigarettes frequently add fuel, food, and beverages in the same transaction. Fewer tobacco trips mean lower overall foot traffic, which compounds the revenue impact well beyond the tobacco line itself.
The Illicit Tobacco Problem: A Risk to Assess
Illicit tobacco is a policy, compliance and safety issue. Its effect on a particular listed retailer cannot be inferred from a national headline figure: use current company disclosures, government data and the business mix of the relevant operator before drawing an investment conclusion.
The Australian Criminal Intelligence Commission (ACIC) estimates the illicit tobacco trade costs the Australian economy approximately $4 billion annually. Arson attacks on tobacco retailers have also introduced operational and reputational risk for listed convenience operators. Together, these forces — falling legal volumes, organised crime involvement, and compliance cost — directly undermine the revenue assumptions embedded in analyst models for listed retailers.
Consumer Staples Versus Consumer Discretionary: Sector-Level Mapping
Within the ASX sector classification, convenience and petrol retail sits within consumer staples sub-sectors, while the downstream spending effects ripple into consumer discretionary. As tobacco prices rise, lower-income households redirect spend away from discretionary categories, tightening conditions for discount retail stocks exposed to budget-constrained consumers.
Investors holding broad consumer staples ETFs should review their underlying exposures for convenience and petrol chain holdings.
Which ASX stocks lose from falling smoking rates?
Smoking Cessation and Healthcare Demand
Changes in smoking prevalence, tobacco policy and access to cessation support can affect healthcare demand. They do not by themselves establish a revenue benefit for a pharmacy, insurer or healthcare company; assess each company’s current disclosures and operating mix.
ASX-listed pharmacy operators are direct beneficiaries. PBS-listed cessation pharmacotherapies drive both prescription volume and associated foot traffic into pharmacy formats.
The 2024 Vaping Regulatory Change
Since 1 October 2024, adults aged 18 and over can buy therapeutic vapes containing 20 mg/mL of nicotine or less from participating pharmacies without a prescription after a pharmacist consultation. Higher-strength products still require a prescription and general retail sales remain banned. The rule change does not itself establish a revenue outcome for any listed company.
The regulatory environment remains fluid. Investor assumptions about the pace and permanence of this redirect should be stress-tested as policy continues to evolve.
Long-Term Healthcare Effects
Population-health changes can take years to flow through to healthcare use and insurance claims. Evaluate a listed company’s current business mix, disclosures and forecasts rather than treating smoking prevalence as a stand-alone investment signal.
These long-run tailwinds operate on a fundamentally different time horizon than near-term cessation revenue. Investors should not conflate the two when assessing healthcare sector positioning.
How does tobacco excise affect Australian consumer stocks?
Mapping Tobacco Exposure in Your SMSF or ETF Holdings
Many Australian super and ETF holdings carry meaningful exposure to global tobacco majors, largely through broad-market international ETFs. Many investors carry this exposure without awareness.
ESG-screened fund options exist on the ASX, but they frequently carry different income profiles and franking credit yields compared to broad-market equivalents. SMSF trustees must document any decision to include or exclude tobacco-exposed holdings within their written investment strategy to satisfy ATO compliance requirements.
CGT Timing and the Cost of Rotating Out of Tobacco-Exposed Positions
Switching from tobacco-exposed consumer staples or ETFs into healthcare or pharmacy alternatives constitutes a CGT event. Individuals and trusts holding assets for more than 12 months access the 50% CGT discount. Complying SMSFs receive a one-third CGT discount — not 50%.
Parcel-level record-keeping is material to the after-tax outcome. The ATO requires investors to retain records for five years. Financial year timing also matters: realising gains across two financial years spreads the tax liability and reduces the risk of a single-year spike in assessable income.
Thinking About Sector Rotation: From Consumer Staples to Healthcare
The conceptual case for shifting sector exposure from tobacco-linked consumer staples toward pharmacy and healthcare is grounded in the structural signals above. Dollar-cost averaging into healthcare positions over time avoids triggering a large single CGT event while gradually adjusting sector weight.
Franking credit profiles differ between consumer staples incumbents and healthcare growth stocks, which affects after-tax income for yield-focused investors. A platform like Crowdfolio helps Australian DIY investors track parcel-level CGT positions, sector weights, and franking credit income across their portfolio — useful when modelling a rotation before executing it. Weigh structural signals against your own income needs, time horizon, and tax position before acting.
FAQ
1. How does Australia’s tobacco excise rate increase affect convenience store and petrol station stocks on the ASX?
Tobacco products represent a substantial share of total revenue at Australian convenience store and petrol station formats. As legal tobacco volumes contract — driven by both declining smoking rates and the growing illicit market — operators face a structural revenue headwind. Higher per-unit prices provide some offset, but falling transaction volumes reduce foot traffic and associated basket spend.
2. Which ASX healthcare stocks could benefit from falling smoking rates and rising demand for smoking cessation products?
ASX-listed pharmacy operators are the most direct near-term beneficiaries, given rising demand for NRT and the 2024 shift to a pharmacy-based vaping model. Over a longer horizon, private health insurers and respiratory or oncology-exposed healthcare stocks benefit as the chronic disease burden associated with smoking gradually declines.
3. What is AWOTE indexation and how often does it increase the tobacco excise rate in Australia?
AWOTE stands for Average Weekly Ordinary Time Earnings. The ATO adjusts Australia’s tobacco excise twice yearly, in March and September, in line with AWOTE movements. Since 1 September 2023, an additional 5% annual increase has been layered on top for three consecutive years.
4. Do Australian ETFs or superannuation funds hold global tobacco company stocks, and should SMSF investors be concerned?
Many Australian super funds and ETFs carry exposure to global tobacco majors, largely through broad-market international ETFs. ESG-screened alternatives exist on the ASX but carry different income and franking credit profiles. SMSF trustees should document any decision to include or exclude tobacco-exposed holdings in their written investment strategy to satisfy ATO compliance requirements.